Citalopram Drug Interactions
371Total Interactions
206Severe
7Moderate
0Mild
| Drug | Severity | Summary |
|---|---|---|
| Acalabrutinib | SEVERE | Both Citalopram and Acalabrutinib can increase the risk of bleeding. |
| Aceclofenac | SEVERE | Both Citalopram and Aceclofenac can increase the risk of bleeding. |
| Acenocoumarol | SEVERE | Acenocoumarol causes bleeding, as can Citalopram ; concurrent use might increase the risk of deve... |
| Alprostadil | SEVERE | Both Citalopram and Alprostadil can increase the risk of bleeding. |
| Alteplase | SEVERE | Alteplase causes bleeding, as can Citalopram ; concurrent use might increase the risk of developi... |
| Amifampridine | SEVERE | Both Citalopram and Amifampridine prolong the QT interval. Most manufacturers advise avoiding the... |
| Aminophylline | SEVERE | Aminophylline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Amiodarone | SEVERE | Both Citalopram and Amiodarone prolong the QT interval. Most manufacturers advise avoiding the us... |
| Amisulpride | SEVERE | Both Citalopram and Amisulpride prolong the QT interval. Most manufacturers advise avoiding the u... |
| Amphotericin B | SEVERE | Amphotericin B is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Anagrelide | SEVERE | Both Citalopram and Anagrelide prolong the QT interval. Most manufacturers advise avoiding the us... |
| Apalutamide | SEVERE | Both Citalopram and Apalutamide prolong the QT interval. Most manufacturers advise avoiding the u... |
| Apixaban | SEVERE | Apixaban causes bleeding, as can Citalopram ; concurrent use might increase the risk of developin... |
| Apomorphine | SEVERE | Both Citalopram and Apomorphine prolong the QT interval. Most manufacturers advise avoiding the u... |
| Argatroban | SEVERE | Argatroban causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Aripiprazole | SEVERE | Both Citalopram and Aripiprazole prolong the QT interval. Most manufacturers advise avoiding the ... |
| Arsenic trioxide | SEVERE | Both Citalopram and Arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding ... |
| Artemether | SEVERE | Both Citalopram and Artemether prolong the QT interval. Most manufacturers advise avoiding the us... |
| Artenimol | SEVERE | Both Citalopram and Artenimol prolong the QT interval. Most manufacturers advise avoiding the use... |
| Asparaginase | SEVERE | Asparaginase causes bleeding, as can Citalopram ; concurrent use might increase the risk of devel... |
| Aspirin | SEVERE | Both Citalopram and Aspirin can increase the risk of bleeding. |
| Avapritinib | SEVERE | Citalopram might increase the risk of bleeding when given with Avapritinib. Manufacturer advises ... |
| Axitinib | SEVERE | Both Citalopram and Axitinib can increase the risk of bleeding. |
| Beclometasone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Bedaquiline | SEVERE | Both Citalopram and Bedaquiline prolong the QT interval. Most manufacturers advise avoiding the u... |
| Bemiparin | SEVERE | Bemiparin causes bleeding, as can Citalopram ; concurrent use might increase the risk of developi... |
| Bendroflumethiazide | SEVERE | Bendroflumethiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsad... |
| Benzydamine | SEVERE | Both Citalopram and Benzydamine can increase the risk of bleeding. |
| Betamethasone | SEVERE | Betamethasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Bevacizumab | SEVERE | Citalopram causes bleeding, as can Bevacizumab ; concurrent use might increase the risk of develo... |
| Bivalirudin | SEVERE | Bivalirudin causes bleeding, as can Citalopram ; concurrent use might increase the risk of develo... |
| Bosutinib | SEVERE | Both Citalopram and Bosutinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Bromfenac | SEVERE | Both Citalopram and Bromfenac can increase the risk of bleeding. |
| Budesonide | SEVERE | Budesonide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Bumetanide | SEVERE | Bumetanide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Bupropion | SEVERE | Bupropion might enhance the risk of serotonin syndrome when given with Citalopram. MHRA advises m... |
| Cabozantinib | SEVERE | Citalopram causes bleeding, as can Cabozantinib ; concurrent use might increase the risk of devel... |
| Cangrelor | SEVERE | Both Citalopram and Cangrelor can increase the risk of bleeding. |
| Caplacizumab | SEVERE | Citalopram causes bleeding, as can Caplacizumab ; concurrent use might increase the risk of devel... |
| Celecoxib | SEVERE | Both Citalopram and Celecoxib can increase the risk of bleeding. |
| Ceritinib | SEVERE | Both Citalopram and Ceritinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Chlorothiazide | SEVERE | Chlorothiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Chlorpromazine | SEVERE | Both Citalopram and Chlorpromazine prolong the QT interval. Most manufacturers advise avoiding th... |
| Chlortalidone | SEVERE | Chlortalidone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Cilostazol | SEVERE | Both Citalopram and Cilostazol can increase the risk of bleeding. |
| Clomipramine | SEVERE | Both Citalopram and Clomipramine prolong the QT interval. Most manufacturers advise avoiding the ... |
| Clopidogrel | SEVERE | Both Citalopram and Clopidogrel can increase the risk of bleeding. |
| Cobimetinib | SEVERE | Citalopram causes bleeding, as can Cobimetinib ; concurrent use might increase the risk of develo... |
| Crisantaspase | SEVERE | Crisantaspase causes bleeding, as can Citalopram ; concurrent use might increase the risk of deve... |
| Crizotinib | SEVERE | Both Citalopram and Crizotinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Dabigatran | SEVERE | Dabigatran causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Dalteparin | SEVERE | Dalteparin causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Danaparoid | SEVERE | Danaparoid causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Dasatinib | SEVERE | Both Citalopram and Dasatinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Deflazacort | SEVERE | Deflazacort is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Delamanid | SEVERE | Both Citalopram and Delamanid prolong the QT interval. Most manufacturers advise avoiding the use... |
| Desflurane | SEVERE | Both Citalopram and Desflurane prolong the QT interval. Most manufacturers advise avoiding the us... |
| Dexamethasone | SEVERE | Dexamethasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Dexketoprofen | SEVERE | Both Citalopram and Dexketoprofen can increase the risk of bleeding. |
| Diclofenac | SEVERE | Both Citalopram and Diclofenac can increase the risk of bleeding. |
| Dipyridamole | SEVERE | Both Citalopram and Dipyridamole can increase the risk of bleeding. |
| Disopyramide | SEVERE | Both Citalopram and Disopyramide prolong the QT interval. Most manufacturers advise avoiding the ... |
| Domperidone | SEVERE | Domperidone increases the risk of QT-prolongation when given with Citalopram. Manufacturer advise... |
| Donanemab | SEVERE | Donanemab can increase the risk of bleeding when given with Citalopram. Manufacturer makes no rec... |
| Dronedarone | SEVERE | Dronedarone is predicted to increase the exposure to Citalopram. Manufacturer makes no recommenda... |
| Droperidol | SEVERE | Both Citalopram and Droperidol prolong the QT interval. Most manufacturers advise avoiding the us... |
| Duloxetine | SEVERE | Both Citalopram and Duloxetine can increase the risk of bleeding. |
| Edoxaban | SEVERE | Edoxaban causes bleeding, as can Citalopram ; concurrent use might increase the risk of developin... |
| Efavirenz | SEVERE | Both Citalopram and Efavirenz prolong the QT interval. Most manufacturers advise avoiding the use... |
| Encorafenib | SEVERE | Both Citalopram and Encorafenib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Enoxaparin | SEVERE | Enoxaparin causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Entrectinib | SEVERE | Both Citalopram and Entrectinib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Epoprostenol | SEVERE | Both Citalopram and Epoprostenol can increase the risk of bleeding. |
| Eptifibatide | SEVERE | Eptifibatide causes bleeding, as can Citalopram ; concurrent use might increase the risk of devel... |
| Eribulin | SEVERE | Both Citalopram and Eribulin prolong the QT interval. Most manufacturers advise avoiding the use ... |
| Erythromycin | SEVERE | Both Citalopram and Erythromycin prolong the QT interval. Most manufacturers advise avoiding the ... |
| Esomeprazole | SEVERE | Esomeprazole increases the exposure to Citalopram. Manufacturer advises monitor and adjust dose. |
| Etodolac | SEVERE | Both Citalopram and Etodolac can increase the risk of bleeding. |
| Etoricoxib | SEVERE | Both Citalopram and Etoricoxib can increase the risk of bleeding. |
| Etrasimod | SEVERE | Etrasimod might increase the risk of QT-prolongation when given with Citalopram. Manufacturer adv... |
| Fingolimod | SEVERE | Fingolimod might increase the risk of QT-prolongation when given with Citalopram. Manufacturer ad... |
| Fluconazole | SEVERE | Both Citalopram and Fluconazole prolong the QT interval. Most manufacturers advise avoiding the u... |
| Fludrocortisone | SEVERE | Fludrocortisone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de... |
| Flurbiprofen | SEVERE | Both Citalopram and Flurbiprofen can increase the risk of bleeding. |
| Fluvoxamine | SEVERE | Fluvoxamine is predicted to increase the exposure to Citalopram. Manufacturer advises monitor and... |
| Fondaparinux | SEVERE | Fondaparinux causes bleeding, as can Citalopram ; concurrent use might increase the risk of devel... |
| Formoterol | SEVERE | Formoterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Furosemide | SEVERE | Furosemide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Glasdegib | SEVERE | Both Citalopram and Glasdegib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Granisetron | SEVERE | Granisetron is predicted to increase the risk of QT-prolongation when given with Citalopram. Manu... |
| Haloperidol | SEVERE | Both Citalopram and Haloperidol prolong the QT interval. Most manufacturers advise avoiding the u... |
| Heparin | SEVERE | Heparin causes bleeding, as can Citalopram ; concurrent use might increase the risk of developing... |
| Hydrochlorothiazide | SEVERE | Hydrochlorothiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsad... |
| Hydrocortisone | SEVERE | Hydrocortisone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Hydroflumethiazide | SEVERE | Hydroflumethiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsade... |
| Hydroxychloroquine | SEVERE | Both Citalopram and Hydroxychloroquine prolong the QT interval. Most manufacturers advise avoidin... |
| Hydroxyzine | SEVERE | Both Citalopram and Hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the u... |
| Ibrutinib | SEVERE | Both Citalopram and Ibrutinib can increase the risk of bleeding. |
| Ibuprofen | SEVERE | Both Citalopram and Ibuprofen can increase the risk of bleeding. |
| Icosapent | SEVERE | Both Citalopram and Icosapent can increase the risk of bleeding. |
| Iloprost | SEVERE | Both Citalopram and Iloprost can increase the risk of bleeding. |
| Imatinib | SEVERE | Both Citalopram and Imatinib can increase the risk of bleeding. |
| Indacaterol | SEVERE | Indacaterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Indapamide | SEVERE | Indapamide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Indometacin | SEVERE | Both Citalopram and Indometacin can increase the risk of bleeding. |
| Inotersen | SEVERE | Citalopram causes bleeding, as can Inotersen ; concurrent use might increase the risk of developi... |
| Inotuzumab ozogamicin | SEVERE | Both Citalopram and Inotuzumab ozogamicin prolong the QT interval. Most manufacturers advise avoi... |
| Isoflurane | SEVERE | Both Citalopram and Isoflurane prolong the QT interval. Most manufacturers advise avoiding the us... |
| Isoprenaline | SEVERE | Isoprenaline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ivabradine | SEVERE | Ivabradine is predicted to increase the risk of torsade de pointes when given with Citalopram. Ma... |
| Ivosidenib | SEVERE | Both Citalopram and Ivosidenib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Ketoprofen | SEVERE | Both Citalopram and Ketoprofen can increase the risk of bleeding. |
| Ketorolac | SEVERE | Both Citalopram and Ketorolac can increase the risk of bleeding. |
| Lapatinib | SEVERE | Both Citalopram and Lapatinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Lecanemab | SEVERE | Lecanemab can increase the risk of bleeding when given with Citalopram. Manufacturer makes no rec... |
| Lenvatinib | SEVERE | Both Citalopram and Lenvatinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Levomepromazine | SEVERE | Both Citalopram and Levomepromazine prolong the QT interval. Most manufacturers advise avoiding t... |
| Mefenamic acid | SEVERE | Both Citalopram and Mefenamic acid can increase the risk of bleeding. |
| Mefloquine | SEVERE | Mefloquine is predicted to increase the risk of QT-prolongation when given with Citalopram. Manuf... |
| Meloxicam | SEVERE | Both Citalopram and Meloxicam can increase the risk of bleeding. |
| Methadone | SEVERE | Both Citalopram and Methadone prolong the QT interval. Most manufacturers advise avoiding the use... |
| Methylprednisolone | SEVERE | Methylprednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade... |
| Metolazone | SEVERE | Metolazone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Mizolastine | SEVERE | Mizolastine is predicted to increase the risk of QT-prolongation when given with Citalopram. Manu... |
| Moxifloxacin | SEVERE | Both Citalopram and Moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the ... |
| Nabumetone | SEVERE | Both Citalopram and Nabumetone can increase the risk of bleeding. |
| Naproxen | SEVERE | Both Citalopram and Naproxen can increase the risk of bleeding. |
| Nicotinic acid | SEVERE | Nicotinic acid causes bleeding, as can Citalopram ; concurrent use might increase the risk of dev... |
| Nilotinib | SEVERE | Both Citalopram and Nilotinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Nintedanib | SEVERE | Both Citalopram and Nintedanib can increase the risk of bleeding. |
| Olodaterol | SEVERE | Olodaterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Omega-3-acid ethyl esters | SEVERE | Both Citalopram and Omega-3-acid ethyl esters can increase the risk of bleeding. |
| Omeprazole | SEVERE | Omeprazole moderately increases the exposure to Citalopram. Manufacturer advises monitor and adju... |
| Ondansetron | SEVERE | Both Citalopram and Ondansetron prolong the QT interval. Most manufacturers advise avoiding the u... |
| Osilodrostat | SEVERE | Both Citalopram and Osilodrostat prolong the QT interval. Most manufacturers advise avoiding the ... |
| Osimertinib | SEVERE | Both Citalopram and Osimertinib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Ozanimod | SEVERE | Citalopram might increase the risk of adverse effects when given with Ozanimod. Manufacturer make... |
| Paliperidone | SEVERE | Both Citalopram and Paliperidone prolong the QT interval. Most manufacturers advise avoiding the ... |
| Palonosetron | SEVERE | Palonosetron is predicted to increase the risk of QT-prolongation when given with Citalopram. Man... |
| Panobinostat | SEVERE | Both Citalopram and Panobinostat prolong the QT interval. Most manufacturers advise avoiding the ... |
| Parecoxib | SEVERE | Both Citalopram and Parecoxib can increase the risk of bleeding. |
| Pasireotide | SEVERE | Both Citalopram and Pasireotide prolong the QT interval. Most manufacturers advise avoiding the u... |
| Pazopanib | SEVERE | Both Citalopram and Pazopanib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Pegaspargase | SEVERE | Pegaspargase causes bleeding, as can Citalopram ; concurrent use might increase the risk of devel... |
| Pentamidine | SEVERE | Pentamidine (intravenous or intramuscular) might increase the risk of QT-prolongation when given ... |
| Pentosan | SEVERE | Pentosan causes bleeding, as can Citalopram ; concurrent use might increase the risk of developin... |
| Phenazone | SEVERE | Both Citalopram and Phenazone can increase the risk of bleeding. |
| Phenindione | SEVERE | Phenindione causes bleeding, as can Citalopram ; concurrent use might increase the risk of develo... |
| Pimozide | SEVERE | Both Citalopram and Pimozide prolong the QT interval. Most manufacturers advise avoiding the use ... |
| Piroxicam | SEVERE | Both Citalopram and Piroxicam can increase the risk of bleeding. |
| Ponatinib | SEVERE | Both Citalopram and Ponatinib can increase the risk of bleeding. |
| Ponesimod | SEVERE | Ponesimod might increase the risk of QT-prolongation when given with Citalopram. Manufacturer adv... |
| Prasugrel | SEVERE | Both Citalopram and Prasugrel can increase the risk of bleeding. |
| Prednisolone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Promethazine | SEVERE | Both Citalopram and Promethazine prolong the QT interval. Most manufacturers advise avoiding the ... |
| Quinine | SEVERE | Both Citalopram and Quinine prolong the QT interval. Most manufacturers advise avoiding the use o... |
| Quizartinib | SEVERE | Both Citalopram and Quizartinib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Ranibizumab | SEVERE | Citalopram causes bleeding, as can Ranibizumab ; concurrent use might increase the risk of develo... |
| Ranolazine | SEVERE | Both Citalopram and Ranolazine prolong the QT interval. Most manufacturers advise avoiding the us... |
| Regorafenib | SEVERE | Both Citalopram and Regorafenib can increase the risk of bleeding. |
| Ribociclib | SEVERE | Both Citalopram and Ribociclib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Rivaroxaban | SEVERE | Rivaroxaban causes bleeding, as can Citalopram ; concurrent use might increase the risk of develo... |
| Ruxolitinib | SEVERE | Citalopram causes bleeding, as can Ruxolitinib ; concurrent use might increase the risk of develo... |
| Salbutamol | SEVERE | Salbutamol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Salmeterol | SEVERE | Salmeterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Selpercatinib | SEVERE | Both Citalopram and Selpercatinib prolong the QT interval. Most manufacturers advise avoiding the... |
| Sevoflurane | SEVERE | Both Citalopram and Sevoflurane prolong the QT interval. Most manufacturers advise avoiding the u... |
| Siponimod | SEVERE | Siponimod might increase the risk of QT-prolongation when given with Citalopram. Manufacturer adv... |
| Sorafenib | SEVERE | Both Citalopram and Sorafenib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Sotalol | SEVERE | Both Citalopram and Sotalol prolong the QT interval. Most manufacturers advise avoiding the use o... |
| Streptokinase | SEVERE | Streptokinase causes bleeding, as can Citalopram ; concurrent use might increase the risk of deve... |
| Sulindac | SEVERE | Both Citalopram and Sulindac can increase the risk of bleeding. |
| Sunitinib | SEVERE | Both Citalopram and Sunitinib prolong the QT interval. Most manufacturers advise avoiding the use... |
| Tapentadol | SEVERE | Tapentadol is predicted to increase the risk of serotonin syndrome when given with Citalopram. Ma... |
| Tenecteplase | SEVERE | Tenecteplase causes bleeding, as can Citalopram ; concurrent use might increase the risk of devel... |
| Tenoxicam | SEVERE | Both Citalopram and Tenoxicam can increase the risk of bleeding. |
| Terbutaline | SEVERE | Terbutaline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Tetrabenazine | SEVERE | Both Citalopram and Tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the... |
| Theophylline | SEVERE | Theophylline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Tiaprofenic acid | SEVERE | Both Citalopram and Tiaprofenic acid can increase the risk of bleeding. |
| Ticagrelor | SEVERE | Both Citalopram and Ticagrelor can increase the risk of bleeding. |
| Tinzaparin | SEVERE | Tinzaparin causes bleeding, as can Citalopram ; concurrent use might increase the risk of develop... |
| Tirofiban | SEVERE | Tirofiban causes bleeding, as can Citalopram ; concurrent use might increase the risk of developi... |
| Tolfenamic acid | SEVERE | Both Citalopram and Tolfenamic acid can increase the risk of bleeding. |
| Tolterodine | SEVERE | Both Citalopram and Tolterodine prolong the QT interval. Most manufacturers advise avoiding the u... |
| Torasemide | SEVERE | Torasemide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Toremifene | SEVERE | Both Citalopram and Toremifene prolong the QT interval. Most manufacturers advise avoiding the us... |
| Trametinib | SEVERE | Citalopram causes bleeding, as can Trametinib ; concurrent use might increase the risk of develop... |
| Trastuzumab emtansine | SEVERE | Citalopram causes bleeding, as can Trastuzumab emtansine ; concurrent use might increase the risk... |
| Treprostinil | SEVERE | Both Citalopram and Treprostinil can increase the risk of bleeding. |
| Triamcinolone | SEVERE | Triamcinolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Urokinase | SEVERE | Urokinase causes bleeding, as can Citalopram ; concurrent use might increase the risk of developi... |
| Vamorolone | SEVERE | Vamorolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Vandetanib | SEVERE | Both Citalopram and Vandetanib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Vardenafil | SEVERE | Both Citalopram and Vardenafil prolong the QT interval. Most manufacturers advise avoiding the us... |
| Vemurafenib | SEVERE | Both Citalopram and Vemurafenib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Venlafaxine | SEVERE | Both Citalopram and Venlafaxine can increase the risk of bleeding. |
| Vernakalant | SEVERE | Both Citalopram and Vernakalant prolong the QT interval. Most manufacturers advise avoiding the u... |
| Vilanterol | SEVERE | Vilanterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Voclosporin | SEVERE | Both Citalopram and Voclosporin prolong the QT interval. Most manufacturers advise avoiding the u... |
| Volanesorsen | SEVERE | Citalopram causes bleeding, as can Volanesorsen ; concurrent use might increase the risk of devel... |
| Voriconazole | SEVERE | Voriconazole is predicted to increase the exposure to Citalopram. Manufacturer makes no recommend... |
| Vortioxetine | SEVERE | Both Citalopram and Vortioxetine can increase the risk of bleeding. |
| Warfarin | SEVERE | Warfarin causes bleeding, as can Citalopram ; concurrent use might increase the risk of developin... |
| Xipamide | SEVERE | Xipamide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de pointe... |
| Zanubrutinib | SEVERE | Both Citalopram and Zanubrutinib can increase the risk of bleeding. |
| Cimetidine | MODERATE | Cimetidine slightly increases the exposure to Citalopram. Manufacturer advises adjust dose. |
| Cobicistat | MODERATE | Cobicistat is predicted to increase the exposure to Citalopram. Manufacturer advises monitor and ... |
| Cyproheptadine | MODERATE | Cyproheptadine potentially decreases the effects of Citalopram. Manufacturer makes no recommendat... |
| Rifampicin | MODERATE | Rifampicin is predicted to decrease the exposure to Citalopram. Manufacturer makes no recommendat... |
| Sparsentan | MODERATE | Sparsentan is predicted to decrease the exposure to Citalopram. Manufacturer advises caution. |
| Terbinafine | MODERATE | Terbinafine is predicted to increase the exposure to Citalopram. Manufacturer makes no recommenda... |
| Vasopressin | MODERATE | Citalopram might enhance the antidiuretic and hypertensive effects of Vasopressin. Manufacturer m... |
| Agomelatine | LOW | Both Citalopram and Agomelatine have effects on the CNS and can cause sedation, which might affec... |
| Alcohol | LOW | Both Citalopram and Alcohol have effects on the CNS and can cause sedation, which might affect th... |
| Alfentanil | LOW | Both Citalopram and Alfentanil have effects on the CNS and can cause sedation, which might affect... |
| Alimemazine | LOW | Both Citalopram and Alimemazine have effects on the CNS and can cause sedation, which might affec... |
| Almotriptan | LOW | Both Citalopram and Almotriptan can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Alprazolam | LOW | Both Citalopram and Alprazolam have effects on the CNS and can cause sedation, which might affect... |
| Amiloride | LOW | Both Citalopram and Amiloride can increase the risk of hyponatraemia. |
| Amitriptyline | LOW | Both Citalopram and Amitriptyline can increase the risk of hyponatraemia. |
| Apraclonidine | LOW | Both Citalopram and Apraclonidine have effects on the CNS and can cause sedation, which might aff... |
| Asenapine | LOW | Both Citalopram and Asenapine can increase the risk of hyponatraemia. |
| Baclofen | LOW | Both Citalopram and Baclofen have effects on the CNS and can cause sedation, which might affect t... |
| Benperidol | LOW | Both Citalopram and Benperidol can increase the risk of hyponatraemia. |
| Brimonidine | LOW | Both Citalopram and Brimonidine have effects on the CNS and can cause sedation, which might affec... |
| Bromocriptine | LOW | Both Citalopram and Bromocriptine have effects on the CNS and can cause sedation, which might aff... |
| Buclizine | LOW | Both Citalopram and Buclizine have effects on the CNS and can cause sedation, which might affect ... |
| Buprenorphine | LOW | Both Citalopram and Buprenorphine have effects on the CNS and can cause sedation, which might aff... |
| Cabergoline | LOW | Both Citalopram and Cabergoline have effects on the CNS and can cause sedation, which might affec... |
| Cannabidiol | LOW | Both Citalopram and Cannabidiol have effects on the CNS and can cause sedation, which might affec... |
| Carbamazepine | LOW | Both Citalopram and Carbamazepine can increase the risk of hyponatraemia. |
| Carboplatin | LOW | Both Citalopram and Carboplatin can increase the risk of hyponatraemia. |
| Cariprazine | LOW | Both Citalopram and Cariprazine can increase the risk of hyponatraemia. |
| Cenobamate | LOW | Both Citalopram and Cenobamate have effects on the CNS and can cause sedation, which might affect... |
| Chloral hydrate | LOW | Both Citalopram and Chloral hydrate have effects on the CNS and can cause sedation, which might a... |
| Chlordiazepoxide | LOW | Both Citalopram and Chlordiazepoxide have effects on the CNS and can cause sedation, which might ... |
| Chlorphenamine | LOW | Both Citalopram and Chlorphenamine have effects on the CNS and can cause sedation, which might af... |
| Cinnarizine | LOW | Both Citalopram and Cinnarizine have effects on the CNS and can cause sedation, which might affec... |
| Cisplatin | LOW | Both Citalopram and Cisplatin can increase the risk of hyponatraemia. |
| Clobazam | LOW | Both Citalopram and Clobazam have effects on the CNS and can cause sedation, which might affect t... |
| Clomethiazole | LOW | Both Citalopram and Clomethiazole have effects on the CNS and can cause sedation, which might aff... |
| Clonazepam | LOW | Both Citalopram and Clonazepam have effects on the CNS and can cause sedation, which might affect... |
| Clonidine | LOW | Both Citalopram and Clonidine have effects on the CNS and can cause sedation, which might affect ... |
| Clozapine | LOW | Both Citalopram and Clozapine can increase the risk of hyponatraemia. |
| Codeine | LOW | Both Citalopram and Codeine have effects on the CNS and can cause sedation, which might affect th... |
| Cyclizine | LOW | Both Citalopram and Cyclizine have effects on the CNS and can cause sedation, which might affect ... |
| Cyclophosphamide | LOW | Both Citalopram and Cyclophosphamide can increase the risk of hyponatraemia. |
| Daridorexant | LOW | Both Citalopram and Daridorexant have effects on the CNS and can cause sedation, which might affe... |
| Desmopressin | LOW | Both Citalopram and Desmopressin can increase the risk of hyponatraemia. |
| Dexamfetamine | LOW | Both Citalopram and Dexamfetamine can increase the risk of serotonin syndrome. See 'Serotonin syn... |
| Dexmedetomidine | LOW | Both Citalopram and Dexmedetomidine have effects on the CNS and can cause sedation, which might a... |
| Diamorphine | LOW | Both Citalopram and Diamorphine have effects on the CNS and can cause sedation, which might affec... |
| Diazepam | LOW | Both Citalopram and Diazepam have effects on the CNS and can cause sedation, which might affect t... |
| Difelikefalin | LOW | Both Citalopram and Difelikefalin have effects on the CNS and can cause sedation, which might aff... |
| Dihydrocodeine | LOW | Both Citalopram and Dihydrocodeine have effects on the CNS and can cause sedation, which might af... |
| Dimenhydrinate | LOW | Both Citalopram and Dimenhydrinate have effects on the CNS and can cause sedation, which might af... |
| Dipipanone | LOW | Both Citalopram and Dipipanone have effects on the CNS and can cause sedation, which might affect... |
| Dosulepin | LOW | Both Citalopram and Dosulepin can increase the risk of hyponatraemia. |
| Doxepin | LOW | Both Citalopram and Doxepin can increase the risk of hyponatraemia. |
| Doxylamine | LOW | Both Citalopram and Doxylamine have effects on the CNS and can cause sedation, which might affect... |
| Dronabinol | LOW | Both Citalopram and Dronabinol have effects on the CNS and can cause sedation, which might affect... |
| Eletriptan | LOW | Both Citalopram and Eletriptan can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Esketamine | LOW | Both Citalopram and Esketamine have effects on the CNS and can cause sedation, which might affect... |
| Eslicarbazepine | LOW | Both Citalopram and Eslicarbazepine can increase the risk of hyponatraemia. |
| Eszopiclone | LOW | Both Citalopram and Eszopiclone have effects on the CNS and can cause sedation, which might affec... |
| Etomidate | LOW | Both Citalopram and Etomidate have effects on the CNS and can cause sedation, which might affect ... |
| Fenfluramine | LOW | Both Citalopram and Fenfluramine can increase the risk of serotonin syndrome. See 'Serotonin synd... |
| Fentanyl | LOW | Both Citalopram and Fentanyl can increase the risk of serotonin syndrome. See 'Serotonin syndrome... |
| Flupentixol | LOW | Both Citalopram and Flupentixol can increase the risk of hyponatraemia. |
| Flurazepam | LOW | Both Citalopram and Flurazepam have effects on the CNS and can cause sedation, which might affect... |
| Foslevodopa | LOW | Both Citalopram and Foslevodopa have effects on the CNS and can cause sedation, which might affec... |
| Fosphenytoin | LOW | Both Citalopram and Fosphenytoin have effects on the CNS and can cause sedation, which might affe... |
| Frovatriptan | LOW | Both Citalopram and Frovatriptan can increase the risk of serotonin syndrome. See 'Serotonin synd... |
| Gabapentin | LOW | Both Citalopram and Gabapentin have effects on the CNS and can cause sedation, which might affect... |
| Guanfacine | LOW | Both Citalopram and Guanfacine have effects on the CNS and can cause sedation, which might affect... |
| Hydromorphone | LOW | Both Citalopram and Hydromorphone have effects on the CNS and can cause sedation, which might aff... |
| Imipramine | LOW | Both Citalopram and Imipramine can increase the risk of hyponatraemia. |
| Isocarboxazid | LOW | Both Citalopram and Isocarboxazid can increase the risk of serotonin syndrome. See 'Serotonin syn... |
| Ketamine | LOW | Both Citalopram and Ketamine have effects on the CNS and can cause sedation, which might affect t... |
| Ketotifen | LOW | Both Citalopram and Ketotifen have effects on the CNS and can cause sedation, which might affect ... |
| Lamotrigine | LOW | Both Citalopram and Lamotrigine have effects on the CNS and can cause sedation, which might affec... |
| Levetiracetam | LOW | Both Citalopram and Levetiracetam have effects on the CNS and can cause sedation, which might aff... |
| Levodopa | LOW | Both Citalopram and Levodopa have effects on the CNS and can cause sedation, which might affect t... |
| Linezolid | LOW | Both Citalopram and Linezolid can increase the risk of serotonin syndrome. See 'Serotonin syndrom... |
| Lisdexamfetamine | LOW | Both Citalopram and Lisdexamfetamine can increase the risk of serotonin syndrome. See 'Serotonin ... |
| Lithium | LOW | Both Citalopram and Lithium can increase the risk of serotonin syndrome. See 'Serotonin syndrome'... |
| Lofepramine | LOW | Both Citalopram and Lofepramine can increase the risk of hyponatraemia. |
| Lofexidine | LOW | Both Citalopram and Lofexidine have effects on the CNS and can cause sedation, which might affect... |
| Loprazolam | LOW | Both Citalopram and Loprazolam have effects on the CNS and can cause sedation, which might affect... |
| Lorazepam | LOW | Both Citalopram and Lorazepam have effects on the CNS and can cause sedation, which might affect ... |
| Lormetazepam | LOW | Both Citalopram and Lormetazepam have effects on the CNS and can cause sedation, which might affe... |
| Loxapine | LOW | Both Citalopram and Loxapine can increase the risk of hyponatraemia. |
| Lurasidone | LOW | Both Citalopram and Lurasidone can increase the risk of hyponatraemia. |
| Mannitol | LOW | Both Citalopram and Mannitol can increase the risk of hyponatraemia. |
| Melatonin | LOW | Both Citalopram and Melatonin have effects on the CNS and can cause sedation, which might affect ... |
| Meptazinol | LOW | Both Citalopram and Meptazinol have effects on the CNS and can cause sedation, which might affect... |
| Methocarbamol | LOW | Both Citalopram and Methocarbamol have effects on the CNS and can cause sedation, which might aff... |
| Methoxyflurane | LOW | Both Citalopram and Methoxyflurane have effects on the CNS and can cause sedation, which might af... |
| Methylthioninium chloride | LOW | Both Citalopram and Methylthioninium chloride can increase the risk of serotonin syndrome. See 'S... |
| Mianserin | LOW | Both Citalopram and Mianserin have effects on the CNS and can cause sedation, which might affect ... |
| Midazolam | LOW | Both Citalopram and Midazolam have effects on the CNS and can cause sedation, which might affect ... |
| Mirtazapine | LOW | Both Citalopram and Mirtazapine can increase the risk of hyponatraemia. |
| Moclobemide | LOW | Both Citalopram and Moclobemide can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Morphine | LOW | Both Citalopram and Morphine have effects on the CNS and can cause sedation, which might affect t... |
| Moxonidine | LOW | Both Citalopram and Moxonidine have effects on the CNS and can cause sedation, which might affect... |
| Nabilone | LOW | Both Citalopram and Nabilone have effects on the CNS and can cause sedation, which might affect t... |
| Naratriptan | LOW | Both Citalopram and Naratriptan can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Nitrazepam | LOW | Both Citalopram and Nitrazepam have effects on the CNS and can cause sedation, which might affect... |
| Nitrous oxide | LOW | Both Citalopram and Nitrous oxide have effects on the CNS and can cause sedation, which might aff... |
| Nortriptyline | LOW | Both Citalopram and Nortriptyline can increase the risk of hyponatraemia. |
| Olanzapine | LOW | Both Citalopram and Olanzapine can increase the risk of hyponatraemia. |
| Orphenadrine | LOW | Both Citalopram and Orphenadrine have effects on the CNS and can cause sedation, which might affe... |
| Oxazepam | LOW | Both Citalopram and Oxazepam have effects on the CNS and can cause sedation, which might affect t... |
| Oxcarbazepine | LOW | Both Citalopram and Oxcarbazepine can increase the risk of hyponatraemia. |
| Oxycodone | LOW | Both Citalopram and Oxycodone have effects on the CNS and can cause sedation, which might affect ... |
| Oxytocin | LOW | Both Citalopram and Oxytocin can increase the risk of hyponatraemia. |
| Pentazocine | LOW | Both Citalopram and Pentazocine can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Perampanel | LOW | Both Citalopram and Perampanel have effects on the CNS and can cause sedation, which might affect... |
| Pericyazine | LOW | Both Citalopram and Pericyazine can increase the risk of hyponatraemia. |
| Pethidine | LOW | Both Citalopram and Pethidine can increase the risk of serotonin syndrome. See 'Serotonin syndrom... |
| Phenelzine | LOW | Both Citalopram and Phenelzine can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Phenobarbital | LOW | Both Citalopram and Phenobarbital have effects on the CNS and can cause sedation, which might aff... |
| Phenytoin | LOW | Both Citalopram and Phenytoin have effects on the CNS and can cause sedation, which might affect ... |
| Pizotifen | LOW | Both Citalopram and Pizotifen have effects on the CNS and can cause sedation, which might affect ... |
| Pramipexole | LOW | Both Citalopram and Pramipexole have effects on the CNS and can cause sedation, which might affec... |
| Pregabalin | LOW | Both Citalopram and Pregabalin have effects on the CNS and can cause sedation, which might affect... |
| Primidone | LOW | Both Citalopram and Primidone have effects on the CNS and can cause sedation, which might affect ... |
| Prochlorperazine | LOW | Both Citalopram and Prochlorperazine can increase the risk of hyponatraemia. |
| Procyclidine | LOW | Both Citalopram and Procyclidine have effects on the CNS and can cause sedation, which might affe... |
| Promazine | LOW | Both Citalopram and Promazine can increase the risk of hyponatraemia. |
| Propofol | LOW | Both Citalopram and Propofol have effects on the CNS and can cause sedation, which might affect t... |
| Quetiapine | LOW | Both Citalopram and Quetiapine can increase the risk of hyponatraemia. |
| Quinagolide | LOW | Both Citalopram and Quinagolide have effects on the CNS and can cause sedation, which might affec... |
| Rasagiline | LOW | Both Citalopram and Rasagiline can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Remifentanil | LOW | Both Citalopram and Remifentanil have effects on the CNS and can cause sedation, which might affe... |
| Remimazolam | LOW | Both Citalopram and Remimazolam have effects on the CNS and can cause sedation, which might affec... |
| Risperidone | LOW | Both Citalopram and Risperidone can increase the risk of hyponatraemia. |
| Rizatriptan | LOW | Both Citalopram and Rizatriptan can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Ropinirole | LOW | Both Citalopram and Ropinirole have effects on the CNS and can cause sedation, which might affect... |
| Rotigotine | LOW | Both Citalopram and Rotigotine have effects on the CNS and can cause sedation, which might affect... |
| Rufinamide | LOW | Both Citalopram and Rufinamide have effects on the CNS and can cause sedation, which might affect... |
| Safinamide | LOW | Both Citalopram and Safinamide can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Selegiline | LOW | Both Citalopram and Selegiline can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Sodium oxybate | LOW | Both Citalopram and Sodium oxybate have effects on the CNS and can cause sedation, which might af... |
| St John's wort | LOW | Both Citalopram and St John's wort can increase the risk of serotonin syndrome. See 'Serotonin sy... |
| Sufentanil | LOW | Both Citalopram and Sufentanil have effects on the CNS and can cause sedation, which might affect... |
| Sulpiride | LOW | Both Citalopram and Sulpiride can increase the risk of hyponatraemia. |
| Sumatriptan | LOW | Both Citalopram and Sumatriptan can increase the risk of serotonin syndrome. See 'Serotonin syndr... |
| Temazepam | LOW | Both Citalopram and Temazepam have effects on the CNS and can cause sedation, which might affect ... |
| Thalidomide | LOW | Both Citalopram and Thalidomide have effects on the CNS and can cause sedation, which might affec... |
| Thiopental | LOW | Both Citalopram and Thiopental have effects on the CNS and can cause sedation, which might affect... |
| Tizanidine | LOW | Both Citalopram and Tizanidine have effects on the CNS and can cause sedation, which might affect... |
| Tramadol | LOW | Both Citalopram and Tramadol can increase the risk of hyponatraemia. |
| Tranylcypromine | LOW | Both Citalopram and Tranylcypromine can increase the risk of serotonin syndrome. See 'Serotonin s... |
| Trazodone | LOW | Both Citalopram and Trazodone can increase the risk of hyponatraemia. |
| Trifluoperazine | LOW | Both Citalopram and Trifluoperazine can increase the risk of hyponatraemia. |
| Trihexyphenidyl | LOW | Both Citalopram and Trihexyphenidyl have effects on the CNS and can cause sedation, which might a... |
| Trimipramine | LOW | Both Citalopram and Trimipramine can increase the risk of hyponatraemia. |
| Tryptophan | LOW | Both Citalopram and Tryptophan can increase the risk of serotonin syndrome. See 'Serotonin syndro... |
| Valproate | LOW | Both Citalopram and Valproate can increase the risk of hyponatraemia. |
| Vigabatrin | LOW | Both Citalopram and Vigabatrin have effects on the CNS and can cause sedation, which might affect... |
| Vinblastine | LOW | Both Citalopram and Vinblastine can increase the risk of hyponatraemia. |
| Vincristine | LOW | Both Citalopram and Vincristine can increase the risk of hyponatraemia. |
| Vinorelbine | LOW | Both Citalopram and Vinorelbine can increase the risk of hyponatraemia. |
| Zolmitriptan | LOW | Both Citalopram and Zolmitriptan can increase the risk of serotonin syndrome. See 'Serotonin synd... |
| Zolpidem | LOW | Both Citalopram and Zolpidem have effects on the CNS and can cause sedation, which might affect t... |
| Zopiclone | LOW | Both Citalopram and Zopiclone have effects on the CNS and can cause sedation, which might affect ... |
| Zuclopenthixol | LOW | Both Citalopram and Zuclopenthixol can increase the risk of hyponatraemia. |
| Mivacurium | UNKNOWN | Citalopram potentially increases the risk of prolonged neuromuscular blockade when given with Miv... |
| Suxamethonium | UNKNOWN | Citalopram potentially increases the risk of prolonged neuromuscular blockade when given with Sux... |
Check Citalopram against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker